Diagnostics Events Announce Your Event Here
9–11 May 2019 European Society of Thoracic Imaging and the Fleischner Society 2019
On behalf of the European Society of Thoracic Imaging and the Fleischner Society, it is our great pleasure to welcome you to Paris, France from May 09-11, 2019, to the joint meeting of our two societies.
The scientific programme will focus on all aspects of Thoracic Imaging of Respiratory Disease, with lectures on state-of-the-art CT, MRI, interventional radiology together with multidisciplinary scientific presentations on the most recent advances in our specialty. Among evolving topics, lung fibrosis, lung cancer screening, response evaluation criteria and the role of artificial intelligence in thoracic imaging will be covered in detail.
6–9 May 2019 7th International Molecular Diagnostics Europe
Cambridge Healthtech Institute’s Seventh International Molecular Diagnostics Europe event will move to a larger venue for 2019 - the Lisbon Marriott Hotel - from 6-9 May. This meeting provides a nexus for diagnostic developers in academia and industry as well as end users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in the prenatal, oncology, infectious disease, point-of-care, and liquid biopsy fields, plus new coverage of biomarkers for immunotherapy and companion diagnostics for immuno-oncology. This exciting area has attracted attendance of over 400 delegates to learn what novel technologies, platforms and applications are emerging that will impact future healthcare delivery and pharmaceutical research. Join us next spring at this expanding event at the epicenter of diagnostics.
12–15 March 2019 ME/CFS. The biological basis, diagnosis, treatment, and management. International Research Symposium
Emerge is proud to host this international research symposium on ME/CFS supported by funding from the Australian Government Department of Health. It presents an immense opportunity for both local and international scientists to share insights and collaborate, and critically serve the needs of the ME/CFS patient community to be informed and heard. We welcome all those interested in ME/CFS to join us for all or part of the symposium from 12–15 March 2019.
12th March – Afternoon arrival & Cocktail Welcome Reception
13th March – Day 1 Scientific programme
14th March – Day 2 Scientific programme & Symposium Dinner
15th March – Day 3 Clinical Focus & Open Day including a Symposia Summary with Q&A
Key speakers will include: Dr. Neil McGregor, Professor Paul Fisher, Associate Professor Brett Lidbury, Professor Sonya Marshall-Gradisnik and Professor Don Staines. A Special Issue "Biomedical Insights that Inform the Diagnosis of ME/CFS" (https://www.mdpi.com/journal/diagnostics/special_issues/ME_CFS) is edited by Associate Professor Brett Lidbury and Professor Paul Fisher. The Special Issue contains all of the speaker submissions and other accepted manuscripts contributing to our objective for Biomedical Insights that Inform the Diagnosis of ME/CFS. The deadline for submission is on 31 May 2019.
10–15 March 2019 26th International Molecular Medicine Tri-Conference
San Francisco, CA, USA
Join over 3,700 drug discovery, development & diagnostics professionals worldwide at the 26th International Molecular Medicine Tri-Conference!
Spanning five days, the 2019 Tri-Conference includes compelling talks, including case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.
21–22 February 2019 14th Annual Biomarkers Congress
Key Speakers include Directors from AstraZeneca, Novartis, Roche and many more. The 2-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions – from panels and roundtables through to two workshops. It brings together over 350 key opinion leaders in biomarkers.
View the Agenda here: https://bit.ly/2RiDodt
For further information, prices and discounts please contact [email protected]
8–9 November 2018 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress
Oxford Global would like to present to you the 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress to be held on the 8-9 November 2018 in London. It is an outstanding and comprehensive programme discussing the critical developments in shaping next generation sequencing, drug development and personalised healthcare. Celebrating its tenth year anniversary, the congress is part of the Genomics and Synthetic Biology Series. It attracts over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
Benefits of attending
- Learn more about NGS in Pharma: biomarker development, precision medicine and clinical diagnostics. Case studies include: NGS in drug discovery and development, biomarkers for precision therapies and clinical genomics in immunotherapy, oncology, infectious and hereditary diseases as well as pre-natal genetic testing
- NGS and genomics in Healthcare: discuss the use of latest NGS and Genomic technologies in patient care, diagnosis and therapeutic development, clinical diagnostics development, informatics and Genomic profiling
- Discover collaborative solutions to next generations sequencing. This prestigious congress brings together key opinion leaders to discuss topic areas ranging from novel methods to NGS data analysis and whole genome sequencing
8–9 November 2018 6th Annual Single Cell Analysis Congress
Oxford Global would like to present to you the 6th Annual Single Cell Analysis Congress to be held on the 8-9 November 2018 in London. It is an outstanding and comprehensive programme discussing the critical developments in Single Cell technologies and tool development, Single Cell analysis, drug and therapeutic development and personalised healthcare.
Benefits of attending:
- Gain Insights From The Discussion Workshop and Breakfast: 10x Genomics Platform – Updates On The Human Cell Atlas Project
- Discover The Latest Solutions Single Cell Analysis: in sample preparation, single cell isolation, capture & purification, RNA processing and splicing, gene regulation, bioinformatics management and workflow analysis
- Benefit From Pharma Focused Presentations: the use of single cell technologies in drug discovery and development and therapeutic development
- Leveraging From Healthcare Focused Presentations: benchmarking RNA Seq sequencing technologies in the clinic, biopsies and single cell analyses to improve stratification of patient and diagnosis
8–9 November 2018 4th Annual Genome Editing Congress
Join a panel of leading authorities on genomics at Oxford Global’s 4th Annual Genome Editing Congress. Over 600 senior delegates from leading academic institutions and pharmaceutical companies will attend to discuss the latest gene editing technologies gene delivery systems and gene therapy applications.
World-class keynote addresses and ample networking opportunities for Precision Medicine experts will create an interactive platform for high-level scientific and business discussions.
On Day 1 of the conference, esteemed speakers such as Eric Paul Bennett, Associate Professor, University of Copenhagen, and Chase Beisel, Group Leader And Professor, Helmholtz Institute For RNA-Based Research, will discuss how to model the results of different CRISPR delivery formats and how to improve their specificity.
Day 2 presentations feature Danilo Maddalo, Laboratory Head, Novartis, as well as Jenna Bradley, Senior Research Scientist, AstraZeneca who will present on the application of genome editing to preclinical models and drug discovery.
11–12 October 2018 3rd Annual Biomarkers & Precision Medicine USA Congress
San Diego, USA
The 3rd Annual Biomarkers & Precision Medicine USA Congress is part of Oxford Global’s R&D US Series that features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarker & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress.
This event will host over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers
4 Interactive Streams:
- Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
- Personalised Medicine, Companion Diagnostics & Patient Testing. Biomarker Assay Validation and Patient Stratification
- Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
- Biomarker in Clinical Development & Clinical Trials. Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing
Free Pre-Congress Live Webinars 2018
Moving Diagnostic Biomarkers from Bench into the Clinic
Hosted by James Snider, CSO and President, Critical Diagnostics & Elizabeth Somers, Director Diagnostics, Morphotek
Register today, for free: https://bit.ly/2HOCyR7
Moving Biomarkers from Bench into the Clinic
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc & Qing Kang, Senior Scientist, Translational Medicine at Syros Pharmaceuticals
Register today, for free: https://bit.ly/2Kw62VC
Driving Precision Medicine and Advancing Big Data in Drug Development
Hosted by Stefan Scherer, Vice President, Global Head Correlative Science, Novartis
Register today, for free: https://bit.ly/2I3sGGq
16–17 July 2018 International conference on Nuclear medicine and Radiation therapy
17–19 June 2018 20th Symposium on Infections in the Immunocompromised Host
We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics, infections in transplant recipients, invasive fungal infections and resistance, treatment of multi-resistant bacteria, infectious complications in immunocompromised children, life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts, prophylaxis and treatment of viral infections in immunocompromised hosts, and others.
11–12 June 2018 2nd Annual Precision Medicine Congress
Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.
View Agenda: http://bit.ly/2BF20WZ
Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.
4 interactive streams:
- Precision Medicine, Regulation, Reimbursement and Targeted Therapy
- Precision Medicine, Biomarkers and Clinical Development
- Precision Medicine: Genomics, Data analysis and Big Data Management
- Precision Medicine and Diagnostics Development
2018 Live Webinar:
Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now: http://bit.ly/2F8bytZ
2017 Free Webinar Recording:
Clinical Utility of Genomic Testing
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free: http://bit.ly/2B3TOOO
For further information regarding prices and possible discounts, please contact Guillaume Alonso on [email protected] or call +44 (0)1865 248 455.
24–26 May 2018 European Societies of Cardiovascular Radiology and Thoracic Imaging 2018 joint meeting
On behalf of the European Societies of Cardiovascular Radiology and Thoracic Imaging, it is our great pleasure to invite you to join us in Switzerland for the very first joint meeting in the fields Cardiovascular and Thoracic Imaging.
The meeting will be held in Geneva, from 24th to 26th May 2018, at the Centre International de Conférences Genève (CICG).
The scientific programme will focus on all aspects of Cardiovascular and Thoracic Imaging, with an emphasis on lively inter-disciplinary discussion. We will review current best clinical practice and explore future developments in our field. We will offer sessions with the WHO on radiation protection and justification of medical imaging and a large number of joint sessions of the two Societies, with a blend of standard formats and subjects and novel approaches, which we hope you will find stimulating and enjoyable. The programme will encompass state-of-the-art scientific presentations; lectures on molecular imaging, CT, MRI, interventional radiology, leadership and management, medico-legal issues, teleradiology and Big Data;inputs from cardiologists and pulmonologists on how imaging helps plan and monitor patient treatment and follow-up. Poster sessions and popular “hands-on” courses will take place throughout the meeting.
16–17 April 2018 Stem Cell 2018 Conference
The theme of the conference is "Frontiers in Stem Cells & turning ideas in to reality" which will provide an international platform for discussion of present and future challenges in various kind of genetical and immunological diseases and disorder, Stemcell education and expertise meeting.
15–16 February 2018 13th Annual Biomarkers Congress
Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018 in Manchester.
The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.
Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.
Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.
View the Agenda here: http://bit.ly/2v4APod
Free Pre-Congress Live Webinar
Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.
Register today for free: http://bit.ly/2xT7TR9
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact: [email protected]
4–5 December 2017 NGS Tech & Applications Congress
With a focus on applications in healthcare, this conference is designed to help you discover how leaders in the field are using sequencing technology, the challenges they face and the solutions to overcome them.
Join us in examining the latest next-generation sequencing technologies, analysis methods and applications across topics at the frontier of genomics, including nanopore sequencing, personalised medicine and genetic screening.
To view the full list of topics and speakers, visit:
4–5 December 2017 3rd Microfluidics Congress
30 November–1 December 2017 3rd Annual Reproductive Genetic Diagnostics
Hyatt Regency Cambridge, Cambridge, MA
Couples undergoing infertility treatments are more aware than ever of preimplantation genetic screening and diagnosis, yet patients and practitioners alike are still struggling with understanding the technologies being used, their capabilities and limitations, and their clinical, legal, and ethical implications. Cambridge Healthtech Institute’s Third Annual Reproductive Genetic Diagnostics conference aims to highlight a number of technologies and their differences, as well as how effective they are at uncovering a variety of genetic abnormalities. Considerations for mosaic embryos, biopsy techniques, and genetic counseling will also be discussed. Special attention will be paid to expanded carrier screening, its role in the direct-to-consumer market, and the potential for other molecular tests for infertility and implantation failure. Future directions for the role of gene editing and non-invasive embryo diagnostics will also be discussed.
28–29 November 2017 5th Annual Advances in Prenatal Molecular Diagnostics
Hyatt Regency Cambridge, Cambridge, MA
Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated comparisons and examine the implementation, insurance, and clinical challenges associated with each test.
Furthermore, with advances in DNA amplification and sequencing comes greater opportunity to garner more information. Much discussion needs to take place in regards to the role of preconception counseling, expanded carrier screening, whole genome versus whole exome sequencing, and the effect these and any prenatal testing may have on the decision to continue a pregnancy or perform fetal therapy.
8–9 November 2017 Fraunhofer Life Science Symposium 2017
- Point-of-care diagnostic
- Nucleic acid based diagnostics
- Serology bases diagnostics
- Sepsis diagnostics
- Diagnosis of emerging infections
- Biomarker development for diagnostic use
- Veterinary diagnostics
- Next generation sequencing in diagnostics
The deadline for abstract submission is June 1, 2017.
8 November 2017 UK Diagnostics Summit 2017-In association with BIVDA
The 2017 Diagnostics Summit will address how Diagnostics are supporting prevention of hospital admissions across the UK. Drawing on best-practice and expertise from key leaders at the forefront of Diagnostics research and development , the Summit will explore how Diagnostics are being utilised at community and secondary health levels to prevent disease and infection.
We will explore:
- Current diagnostic testing in GP surgeries and Pharmacies
- How Diagnostics can be funded and funding barriers
- Reasearch on rapid testing
- Children diagnostics
- Point of care testing
- The role of diagnostics within pharmacies
- Home care diagnostics
- Education on testing and accuracy
- Patient and Clinical pathways
- Holistic approach to prevention
28–30 September 2017 ESHNR 2017 – 30th Annual Meeting and Refresher Course
On behalf of the European Society of Head and Neck Radiology (ESHNR), we would like to cordially invite you to participate in and support the 30th Annual Meeting and Refresher Course taking place in the city of Lisbon, Portugal from September 28-30, 2017.
The 2017 ESHNR Annual Meeting will gather renowned specialists and enthusiastic speakers in the newest clinical and research hub of Lisbon, facing the Tagus river and the beautiful tower of Belém.
This year’s meeting will focus on new MR imaging and US applications, quantitative multiparametric imaging, standardization of imaging protocols and structured radiologic reports. Acute head and neck trauma, fetal and postnatal imaging, MR neurography and the role of imaging in swallowing and sleep disorders will also be covered. Besides formal lectures, practical workshops and interactive clinical-radiological sessions will also be provided.
Do not miss the opportunity to be a part of this exciting scientific event!
25–27 September 2017 International Conference On Nanomedicine And Nanobiotechnology – ICONAN 2017
The International Conference On Nanomedicine and Nanobiotechnology is an annual event that hosts high-profile plenary speakers, world-class researchers, oral and poster presentations, workshops, sponsor exhibits and afterworks. It is a great opportunity to share your research findings with a wide audience, promote knowledge exchange, and network. The topics includes:
- Targeted drug delivery and nanocarriers
- Nanomedicine for cancer diagnosis & therapy
- Biological & medical nanodevices and biosensors
- Tissue engineering and regenerative nanomedicine
- Toxicology and risk assessment of nanomedicine systems
- Nano-Imaging for diagnosis, therapy and delivery
- Bionanocatalysis and nanobiosystems
- Microfluidics in nanomedicine and nanobiology
20–22 September 2017 10th international symposium on circulating nucleic acids in plasma and serum (CNAPS) Corum
Liquid biopsy is one of the most important emerging field in diagnostics, especially in oncology or prenatal diagnostic since the last decade, and is starting to change practice in standard of care.
The organizing committee warmly welcomes you to the 10th international symposium on circulating nucleic acids in plasma and serum (CNAPS) to be held at the Corum, Montpellier, on 20/22 September 2017.
The first CNAPS meeting was organized in 1997 by circulating nucleic acid pioneers and was the first meeting dedicated to the circulating DNA and RNA field. Such meetings are organized every two years by scientists in either America, Asia or Europe.
CNAPS meetings are unique as they focus on and link together basic and applied research. This event offers a unique opportunity for scientists and clinicians around the world to interact, discuss with companies and share knowledge with colleagues in the broader CNAPS and liquid biopsy community.
The organizing committee:
Safia El Messaoudi
25–26 July 2017 2nd Microfluidics Congress: USA
Philadelphia, PA, USA
UTILIZING MICROFLUIDIC TECHNOLOGIES AS A TOOL FOR PROGRESSING MEDICAL RESEARCH
You are cordially invited to join our community of leading academics and scientists from biotechnology & pharmaceuticals organizations who are working to transform healthcare by harnessing the developments of these new and overlapping technologies.
To foster a collegiate atmosphere and enable the widest possible attendance, the main conference program on July 25-26, is free to attend for delegates.
13–14 July 2017 In Vitro Diagnostics: Infectious Diseases and Oncology Conference
Philadelphia, PA, USA
13–14 July 2017 Next Generation Companion Diagnostics Conference
Philadelphia, PA, USA
MarketsandMarkets is pleased to announce the 'Next Generation Companion Diagnostics Conference’ which will congregate experts from the field of personalized medicine and precision medicine from pharmaceutical and academic institutes and understand the emerging trends and challenges from their perspective.
14–15 June 2017 In Vitro Diagnostics 2017
Holiday Inn Kensington Forum, London, UK
The third in its series, SMi is delighted to announce the return of In Vitro Diagnostics taking place in London on the 14th & 15th June 2017. Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.
Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond. Topics of discussion include: Latest updates on the IVD regulation, the changing role of notified bodies as well as the increase in requirements for clinical evidence.
Speakers include: FDA, MHRA, LNE/GMED North America, LRQA, TÜV SÜD, Ortho Clinical Diagnostics, DEKRA and many more…
Early birds available!
30 May–3 June 2017 ESPR 2017 – 53rd Annual Meeting & 39th Post Graduate Course
It has been more than 20 years since our meeting was held in Lugano/Switzerland, and so much has changed in the world of paediatric radiology, but the only thing that has remained constant is the commitment and the talent of the ESPR community! We sincerely hope that this meeting will provide a platform for networking, will advance education and provide the frame for both, making new and renew old friendships in our alpine city.
The ESPR 2017 course builds on the spirit of previous years and is structured around six pathology-based sessions with functional correlation, one session dedicated to neonatal imaging and one session focused upon radiation protection. The highlight of this course is an international discussion panel with renowned experts who will demonstrate the clinical and radiological features in a case-based session dedicated to child abuse and genetic-metabolic mimickers.
We are living in a rapidly evolving world, in which new diseases and an intensive population exchange across countries are deemed to have a long lasting and global financial and epidemiological impact. We will have two special focus sessions dedicated to emerging infectious diseases like ZIKA virus and to the problem of age assessment in juvenile migrants, highlighting the clinical and radiological aspects of these two new and poorly investigated topics.
To underscore the importance of international communication, two “ESPR meets CHOP” Mini-Symposia will be held, in which eminent European and American experts will exchange their radiological experience and knowledge about various specific diseases including neuroblastoma, sarcoma and many more.
This exciting, thoughtful and stimulating programme would not be possible without the commitment of dozens of members, non-members and vendors willing to support the ESPR by sharing their expertise, time and resources. We are confident that you will find the venue and networking, research and educational opportunities inspirational and fun.
10–11 May 2017 9th Annual Lab-on-a-Chip & Microfluidics
This conference will feature three tracks:
- Biosensors, Microfluidics and Lab-on-a-Chip Technologies
- Point-of-Care Diagnostics 2017
- Organ-on-a-Chip Europe 2017
As a multi-track event, delegates will have unrestricted access to all conference tracks and networking opportunities.
25–26 April 2017 Advances in Companion Diagnostics Congress
Oxford Global Conferences are proud to present the Inaugural Advances in Companion Diagnostics Congress, taking place on the 25-26 April 2017 in London.
200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies
36 presentations and case studies focusing on the key developments in companion diagnostic development, molecular diagnostics, imaging, digital pathology and CDx for NGS technologies
4 interactive streams:
- Companion Diagnostics (CDx) development
- Advances in Molecular Diagnostics
- Imaging and Diagnostic Development
- Companion Diagnostics for Next-Generation Sequencing (NGS) platforms
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with the Inaugural Precision Medicine Congress
3–5 April 2017 AMP 2017 Global Congress on Molecular Pathology: Diagnostic Technologies and Clinical Applications
The Association for Molecular Pathology (AMP) is pleased to invite you to join us for the inaugural AMP 2017 Global Congress on Molecular Pathology: Diagnostic Technologies and Clinical Applications, in Berlin, Germany, April 3-5, 2017. A multi-disciplinary scientific program showcases molecular technology with clinical applications in oncology (solid tumors, hematopathology), genetics (congenital, heritable), and infectious diseases. Importantly, there is an emphasis on modern, user-friendly laboratory analytics supported by informatics tools to facilitate interpretation of actionable genomic test results. The Global Congress brings together a network of molecular professionals and representatives of the diagnostics industry to educate healthcare practitioners and to advance the value of molecular laboratories in providing high quality patient care around the world.
AMP is the premier organization representing the field of molecular diagnostics worldwide. AMP members can be found in 43 countries and are dedicated to advancing molecular medicine around the world.
- Lab Professionals (Directors, Researchers, Supervisors, Managers)
- Clinicians (Oncologists, Geneticists, Infectious Disease and Primary Care Physicians)
- Molecular/Medical Technologists and Doctoral Trainees
3–4 October 2016 Biomarkers & Precision Medicine USA Congress 2016
San Diego, USA
Attended by over 200 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and unprecedented networking opportunities. In line with the current industry trends, day one of the congress focusses on the identification of safety biomarkers, the translation of biomarkers from the discovery to the early development stages as well as personalised healthcare. Expert case studies will also cover insights into novel biomarker discoveries and development in different therapeutic areas such as immune-oncology, CNS diseases, neuroscience & infectious diseases.
The companion diagnostics & personalised medicine stream features the latest updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine & patient self-monitoring in healthcare.
Boston, MA, USA
2nd Cancer Markers & Liquid Biopsies
Digital PCR & qPCR
25–27 May 2016 26th Anniversary World Congress on Biosensors
Swedish Exhibition and Congress Centre, Gothenburg, Sweden
4–7 April 2016 The Fourth International Molecular Diagnostics Europe
Sheration Hotel & Spa Lisbon, Portugal
Novel molecular-based tools are rapidly entering the clinic and creating a new paradigm in healthcare. The Fourth International Molecular Diagnostics Europe event will return to Lisbon this spring and feature six tracks: Prenatal Molecular Diagnostics, Reproductive Genetic Diagnostics, Circulating Tumour Cells, Circulating Cell-Free DNA, Advanced Diagnostics for Infectious Disease, and Point-of-Care Diagnostics. As the prenatal diagnostics market has demonstrated, molecular diagnostics are being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine.
9–10 November 2015 NIH-IEEE 2015 Strategic Conference on Healthcare Innovations and Point-of-Care Technologies for Precision Medicine
NIAID Conference Center, 5601 Fishers Lane, Bethesda, MD 20852, USA
The NIH-IEEE Strategic Conference on Healthcare Innovations and Point-of-Care (POC) Technologies for Precision Medicine will focus on defining clinical translation needs and technology solutions. This 2 day conference will facilitate stakeholder – clinicians, healthcare providers, industry experts, innovators, government representatives, researchers and students – participation in key sessions. They include clinical needs for precision medicine, enabling technologies for POC, regulatory issues for POC devices, and sustainable global business models to support POC technologies in resource limited environments.
Federal funding opportunities and resources will be showcased, and presentations on recent healthcare innovations, point-of-care technologies, and industry exhibits will be featured. Stakeholders will have the opportunity to discuss barriers and challenges in the broad delivery of accurate and affordable healthcare. Breakout sessions will lead to strategic planning on future directions to enhance resources and collaborations for clinical POC technologies.
Who Should Attend: All stakeholders in healthcare innovations, delivery, maintenance, services and management are specifically encouraged to participate in the conference. Researchers, clinicians and students engaged in scientific and clinical research related to healthcare applications are invited to attend. Industries and businesses dealing with healthcare products, devices, pharma and payers, along with life-science related sponsoring agencies and foundations are welcome to participate.
Extended abstracts in the form of 1-page papers of all invited and accepted presentations will be included in the Conference Program Book. The deadline for submission of 1-page papers is September 1, 2015. Full papers on the presentations will be invited for publication in a special issue of the open access IEEE Journal of Translational Engineering in Health and Medicine in early 2016.
3–4 September 2015 Cancer diagnosis & Therapy Congress
Vancouver, British Columbia, Canada
IEEE SysCon seeks to create an interactive forum for the advancement of the practice of systems engineering across the multiple disciplines and specialty areas associated with the engineering of complex systems.
Sarasota, FL, USA
American Medical Seminars, Inc. presents this Live CME Conference in Sarasota, FL. The course is free of Commercial Support and is approved for 20 AMA PRA Category 1 Credits™. Course details and other CME courses can be found at www.ams4cme.com.
Orlando, FL, USA
SPIE Medical Imaging conference, is where the latest information in digital pathology; tomography; image processing, perception, registration, informatics, and segmentation; computer-aided diagnosis; and ultrasound is presented. Whether you are presenting to your peers, or are looking to gain further knowledge to enhance your research area, we welcome your participation.
San Francisco, CA, USA
Now that the goal of moving NGS to the clinic has been accomplished, the next step is to ensure proper usage and adoption. Developing standards, protocols, robustness, cost-effectiveness and reimbursement of assays are all of prime importance. This year’s Personalized Diagnostics conference will review recent progress for building an infrastructure to incorporate the use of NGS and circulating biomarkers in the clinic for cancer, prenatal, cardiovascular, pediatric and genetic disease applications and illustrate value-added testing using case studies.
San Francisco, CA, USA
The growth in the diagnostics sector and personalized therapy is being driven by opportunities in molecular diagnostics. Today, hospitals and healthcare providers need to stay competitive by taking on large-scale projects to match patients with targeted therapy using next generation sequencing and molecular profiling tools. This conference will feature experts on business strategy, platform development, regulation and reimbursement who will outline the steps needed to take to achieve commercial success in the current environment.
San Francisco, CA, USA
The field of companion diagnostics is undergoing radical changes with the battery of sequencing tests available and adoption of new clinical trial protocols. The reality is becoming apparent that a new strategy is needed for implementing and commercializing molecularly guided therapies. More personalized therapies are available but significant questions remain as to how to get patients the treatments best suited to their disease. Multi-gene panels are becoming the standard of care in oncology but the practice is far from commonplace. Practical aspects of reimbursement, regulation, patient payment responsibility, commercial launch and drug development will be covered in this comprehensive program detailing the state-of-the-art process for implementing companion diagnostics.
Kola, Kauai, HT, USA
The program explores approaches to the diagnosis, management and prevention of common rhythm disorders. The diagnoses and management of atrial fibrillation are also reviewed. The program shares pearls to aid in the evaluation and assessment of patients with cardiac arrhythmias. The diagnosis and treatment of patients with congestive heart failure are integrated, as well as valvular heart.
12–15 January 2015 2nd International Conference on Bioimaging (BIOIMAGING 2015)
Bioimaging is a term that covers the complex chain of acquiring, processing and visualizing structural or functional images of living objects or systems, including extraction and processing of image-related information. Examples of image modalities used in bioimaging are many, including: X-ray, CT, MRI and fMRI, PET and HRRT PET, SPECT, MEG and so on. Medical imaging and microscope/fluorescence image processing are important parts of bioimaging referring to the techniques and processes used to create images of the human body, anatomical areas, tissues, and so on, down to the molecular level, for clinical purposes, seeking to reveal, diagnose, or examine diseases, or medical science, including the study of normal anatomy and physiology. Image processing methods, such as denoising, segmentation, deconvolution and registration methods, feature recognition and classification represent an indispensable part of bioimaging, as well as related data analysis and statistical tools.
5–7 November 2014 POC and mHealth Diagnostics Summit
Boston, MA, USA
5–7 November 2014 Advances in Prenatal Molecular Diagnostics
Boston, MA, USA
The field of prenatal diagnostics is undergoing rapid and significant change, as a variety of molecular diagnostics are transforming the type and quality of data that can be provided to pregnant women and their physicians. Array-based cytogenetic analysis can provide more detailed and accurate assessment of many genetic conditions compared with traditional karyotyping, both of which rely on samples obtained using invasive procedures. Since obtaining samples invasively, even in the most proficient hands, does involve some risk to the fetus, there has been tremendous interest in non-invasive testing approaches. Next-gen sequencing of cell-free DNA found in maternal blood has been demonstrated to provide highly accurate assessment of fetal aneuploidies, with quite low false positives and false negatives, in most cases. Best practice guidelines have been modified quite quickly to recommend that such testing be offered to women who are at increased risk of aneuploidies, either because of past history, advanced maternal age or other reasons, and adoption and agreement by insurers to cover such testing has occurred at unprecedented speed. Such tests are not without controversy, however, because they only test for the most common chromosome duplications, and are unable thus far to provide analysis of smaller genetic insertions, deletions and rearrangements. One alternative approach has been research on obtaining circulating fetal cells from maternal blood, which would offer the advantages of being non-invasive, and isolated from confounding maternal DNA, but the challenges of reliably obtaining such rare cells has delayed the prospects for commercialization. This conference will provide an in-depth examination of key issues, technical and practical developments in these areas, and opportunities for discussing some of the issues that will have an impact on how this field continues to quickly evolve in the near future.
6–8 October 2014 Digital PCR Conference: Technologies and Tools for Precision Diagnostics
La Jolla, CA, USA
Digital PCR’s ability to precisely quantitate, identify mutations and copy number variations, and to perform gene expression analysis is creating waves across the diagnostics landscape. It is well suited for single-cell analysis and shows promise to become a superior tool in the clinic due to its capacity to work with small amounts of sample. The Third Annual Digital PCR event will bring together industry visionaries and early adopters to discuss digital PCR’s capabilities, limitations, and future applications. Researchers will examine applications in cancer biomarker and rare mutation detection, non-invasive fetal DNA analysis, and infectious disease quantification, particularly in HIV. Novel digital PCR devices from startups and academic labs will be showcased. Other topics to be addressed include digital PCR integration with existing technologies, solutions for processing difficult samples as well as increasing sample throughput, and guidelines and best practices for digital detection.
15–17 September 2014 Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change
Seattle, WA, USA
Tumor collections provide insight into the great variability of cancer, its progression and its response to treatment. Patient xenografts and cell models (PDX) allow researchers to link and integrate information and determine personal variations in cancer molecular profiles. The recent advancements in high-throughput genomics, proteomics and other -omics platforms allow profiling of large numbers of cancer analytes in a single assay. Thus, knowledge of these altered molecular landscapes offers great promise for developing molecular tests to improve cancer diagnosis and optimize treatment. Cambridge Healthtech Institute’s Inaugural Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change convenes international oncology experts in the fields of tumor biospecimen research, PDX models, molecular diagnostics/prognostics and pharmacogenomics.
19–21 August 2014 Next Generation Dx Summit: Moving Assays to the Clinic
Washington, DC, USA
Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell-free DNA and single-cell sequencing.
Boston, MA, USA
In recent years there have been dramatic changes in the field of prenatal diagnostics, both as a result of new technical capabilities, as well as concerns over the risks and limitations associated with traditional diagnostic approaches. The transition in favor of array-based cytogenetic assays in place of traditional karyotyping is well underway. For higher risk pregnancies, the use of sequence-based testing of cell-free DNA in maternal blood is becoming more common, although evidence of genetic abnormalities must then still be confirmed with more invasive procedures. Research aimed at isolation of nucleated fetal cells from maternal blood could provide better answers with lower risk in the future. Advances in single cell sequencing are being applied to pre-implantation diagnostics and could be particularly powerful when combined with fetal cell isolation from maternal blood. Progress is also being made in the development of biomarkers to assess the risk of both pre-term labor and pre-eclampsia, which offer the potential of much earlier steps to limit these dangers. While technical developments will be important, there are also a number of other factors, including regulatory and reimbursement challenges, as well as clinical and genetic counseling perspectives, that need to be understood in order to forecast how this field is likely to develop over the next few years.
San Diego, CA, USA
Today, innovation is essential for the rapidly evolving diagnostics landscape. While point-of-care testing has the potential to streamline healthcare and improve clinical outcomes, regulators, and clinicians must be creative to translate this potential into a reality. Point-of-Care Diagnostics World Congress will provide an overview of the point-of-care testing landscape, from novel technologies to regulatory approval. Physicians will offer their perspective on point-of-care adoption in the clinical setting as well as in the global health environment. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry to discuss problems, highlight solutions and facilitating collaborations.
The conference will be co-located with Single Cell Analysis Summit, Microarray World Congress and Lab-on-a-Chip World Congress. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.
San Diego, CA, USA
The Lab-on-a-Chip World Congress will bring together leaders from both academia and industry to discuss innovative developments in this exciting field, with presentations exploring the latest advances in microfluidics and microfabrication. Attention will also be given to some of the many applications of Labs-on-Chips, from the enhancement of life science research, to taking diagnostics to the point of need.
- Diagnostics and Medical Applications
- Droplet-Based Microfluidics
- Market Orientated Device
- Nanotech on a Chip
- Point of Care Devices and Diagnostics
- Single Cell Analysis
There is lots of excitement in this field regarding the creation and development of new tools for improving the detection, diagnosis and treatment of diseases at the molecular level. This conference will discuss the expression patterns from both the genome and proteins, and use them to differentiate between what is normal and abnormal. There will be particular focus on point-of-care diagnostics, predictive biomarkers and their discovery and detection. Additionally, the cutting-edge subjects of circulating tumour cells and diagnostic applications of exosomes will be explored, giving delegates a brilliant insight into this rapidly expanding field.
Molecular Medicine Congress will provide the latest novel applications in molecular mechanisms and therapeutic developments. It will also offer new ideas and approaches for research and offer the opportunity for scientists to collaborate with the experts in this field. Our panel of distinguished speakers will present their recent discoveries and most updated scientific information, which will make for a very exciting and rewarding conference to attend.
Our Molecular Medicine Congress 2013 is an international event being hosted in beautiful city of Frankfurt, Germany. Tracks at this event are, Diagnostic Applications of Next Gen Sequencing and Biomarkers and Applications of Exosomes. Registered delegates will have unrestricted access to both meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.
27 August–1 September 2013 EVDI Conference 2013
We would like to invite you to join us for the 2013 EVDI Annual Scientific Meeting, jointly organized by the European College of Veterinary Diagnostic Imaging (ECVDI), the European Association of Veterinary Diagnostic Imaging (EAVDI) and the Portuguese Small Animal Veterinary Association (APMVEAC), which will take place in Cascais, Portugal from the 27th of August to the 1st of September of 2013.
The EVDI Annual Meeting brings together the latest news and advances in veterinary diagnostic imaging, with exceptional educational and scientific value.
This year we also provide an interesting selection of Continuing Professional Development Courses, specially designed for professionals who want to further develop their skills in the a wide variety of veterinary diagnostic imaging fields in small animal and equine medicine.
Washington, DC, USA
Technological advances in next generation diagnostics are driving growth and innovation in healthcare. Rapid and precise diagnosis is essential for personalized medicine and will change the way value is assessed and compensated in the healthcare system. This meeting offers a comprehensive view of the changing landscape of diagnostics and brings together the key players in the field.
The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Molecular Profiling of Circulating Tumor Cells) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what the industry leaders are saying about future market opportunities and network with your peers this August 20-22 in Washington, DC.
The 2013 IEEE/ASME International Conference on Advanced Intelligent Mechatronics will be held on July 9-12, 2013 in Wollongong. AIM 2013 conference brings together an international community of experts to discuss the state-of-the-art, new research results, perspectives of future developments, and innovative applications relevant to mechatronics, robotics, control, automation, and related areas.
The theme of the conference is “Mechatronics for Human Wellbeing”, which emphasises the significance of Mechatronics in enhancing the quality of life for society.
AIM 2013 conference invites submissions of high quality research papers describing original work on the following topics, but not limited to: Actuators, Automotive Systems, Bioengineering, Data Storage Systems, Electronic Packaging, Fault Diagnosis, Human-Machine Interfaces, Industry Applications, Information Technology, Intelligent Systems, Machine Vision, Manufacturing, Micro-Electro-Mechanical Systems, Micro/Nano Technology, Modeling and Design, Motion Vibration and Noise Control, Neural and Fuzzy Control, Opto-Electronic Systems, Prototyping, Real-Time and Hardware-in-the-Loop Simulation, Robotics, Sensors, System Integration, Transportation Systems, Smart Materials and Structures, Energy Harvesting and other frontier fields of mechatronics.
3–6 June 2013 Drug Discovery & Therapy World Congress 2013
Boston, MA, USA
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
The 17th International Conference on Prenatal Diagnosis and Therapy will be held in Lisbon, Portugal, 2 - 5 June 2013. Three days of podium sessions, controversies, symposia and poster sessions will follow a day of preconference courses designed for professionals around the globe engaged in prenatal diagnosis, therapy and research. We look forward to seeing you there! Please check this website for further details as they become available.
ISPD will offer preconference workshops on Sunday, 2 June 2013. ISPD 17th International Conference sessions will be held Monday – Wednesday, 3 – 5 June 2013. The three days of conference sessions will include debates on the latest controversies in the field and concurrent sessions featuring confirmed invited speakers and selected abstract presentations. Please bookmark this website and check it regularly for updates as invited speakers are confirmed.
University of Notre Dame, IN, USA
Advances in Microfluidics & Nanofluidics (AMN) 2013 is the fourth AMN conference after successful meetings previously held in Hong Kong (2009), Singapore (2011) and Dalian, China (2012). The aim of the conference is to provide a forum to promote scientific exchange and to foster closer networks and collaborative ties between leading international micro/nanofluidics researchers across various disciplines from engineering, physics, chemistry, biology, material science and biotechnology.
The scope of AMN 2013 is deliberately broad and interdisciplinary, encompassing the latest advances and the most innovative developments in micro/nanoscale science and technology. Topics range from fundamental research to its applications in chemistry, physics, biology, materials and medicine.
Abstracts for oral and poster presentations are solicited across broad themes centered around fundamentals and applications of micro/nanofluidic science and technology. These include, but are not limited to
Fundamentals in microfluidics and nanofluidics
Novel fluid and transport phenomena at microscale and nanoscale dimensions
Microscale and nanoscale fluid actuation and particle manipulation mechanisms
Chemical and biological sensing techniques
Gene, protein and cell analysis and manipulation
Chemical and biochemical synthesis
Biosensors for biochemical and pathogen detection
Drug screening and drug delivery
Biomaterials synthesis and tissue engineering
Microfuel cells and other energy/environmental applications
Micro/nanofabrication methods and chip-scale integration
Miami, FL, USA
This meeting, which has been held annually since 1982, has steadily grown and typically has over 200 registrants. The conference was started to bring together engineers and scientists in the South with interest in biomedical applications and showcase development in the emerging field of biomedical engineering. It has grown into not only a regional conference, but an international conference with participants from every part of the United States, Canada, South America, Europe, and Asia. The aim of this conference is to bring together researchers, clinicians, students, and industry leaders to discuss current ideas and concepts in biomedical research. The conference cover advances and innovations in Biomedical Engineering and related science, technology and education. Translation of biomedical technology to the clinic, mobile medicine, and innovative application of computational approaches and photonic, micro, nano, and wireless devices for investigating, real-time interfacing and targeted control of physiological function are of special interest. The program agenda includes keynote lectures, presentations in diverse areas of biomedical engineering, and student competitions.
17–18 March 2013 ICBBT 2013—2013 5th International Conference on Bioinformatics and Biomedical Technology
The aim objective of the International Conference on Bioinformatics and Biomedical Technology (ICBBT) is to provide a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development activities in Bioinformatics and Biomedical Technology. Previous ICBBT 2009, 2010, 2011 and 2012 were held in Singapore, Chengdu, Sanya and Singapore respectively. The 2013 5th International Conference on Bioinformatics and Biomedical Technology will be held in Macau during March 17-18, 2013.
Topics: The conference is soliciting state-of-the-art research papers in the following areas of interest:
Bioinformatics and Computational Biology
Protein structure, function and sequence analysis
Protein interactions, docking and function
DNA and RNA structure, function and sequence analysis
Gene regulation, expression, identification and network
Structural, functional and comparative genomics
Gene engineering and protein engineering
Computational evolutionary biology
Drug design and computer aided diagnosis
Data acquisition, normalization, analysis and visualization
Algorithms, models, software, and tools in Bioinformatics
Any novel approaches to bioinformatics problems
Biomedical imaging, image processing & visualization
Bioelectrical and neural engineering
Biomechanics and bio-transport
Methods and biology effects of NMR/CT/ECG technology
Biomedical devices, sensors, and artificial organs
Biochemical, cellular, molecular and tissue engineering
Biomedical robotics and mechanics
Rehabilitation engineering and clinical engineering
Health monitoring systems and wearable system
Bio-signal processing and analysis
Biometric and bio-measurement
Other topics related to biomedical engineering
Other Related Topics
The Lab-on-a-Chip European Congress will bring together leaders from both academia and industry to discuss innovative developments in this exciting field, with presentations exploring the latest advances in microfluidics and microfabrication. Attention will also be given to some of the many applications of Lab-on-a-Chip Technologies, from the enhancement of life science research, to taking diagnostics to the point of need.
Diagnostics and Medical Applications
Market Orientated Device
Nanotech on a chip
Point of Care Devices and Diagnostics
Single Cell Analysis
9–14 February 2013 Medical Imaging 2013
Lake Buena Vista (Orlando Area), FL, USA
Review the latest research at this multidisciplinary, internationally recognized forum for the reporting of cutting-edge research and developments in medical imaging.
- Physics of medical imaging
- Image processing
- Computer-aided diagnosis
- Image-guided procedures, robotic interventions, and modeling
- Biomedical applications in molecular, structural, and functional imaging
- Image perception, observer performance, and technology assessment
- Advanced PACS-based imaging informatics and therapeutic applications
- Ultrasonic imaging, tomography, and therapy
- Digital pathology
12–14 December 2012 2012 HIV Diagnostics Conference
Sheraton Atlanta, GA, USA
The 2012 HIV Diagnostics Conference, co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL), provides an opportunity for clinicians, clinical and public health laboratorians, HIV/AIDS program managers and directors, and industry representatives to review developments in HIV diagnostics, share data and research findings, and establish collaborations. Since its inception in 2005, the HIV Diagnostics Conference has served as an opportunity for those interested in issues related to HIV diagnostic testing to gather and discuss new developments and related prevention and surveillance measures.
- 4th Generation HIV-1/HIV-2 Immunoassay Screening
- HIV Testing Algorithms in the Laboratory
- HIV Testing Algorithms outside the Laboratory
- HIV-1 Nucleic Acid Tests for Diagnosis and Prognosis
- HIV-2 Testing
- Alternatives for Diagnostic Decision Making
- Laboratory and Surveillance Issues
- Diagnostic Assays under Development
- Testing for HIV/HBV and HIV/HCV Co-infections
10–14 November 2012 5th International Conference on Diagnostic Error in Medicine (DEM)—2012
Johns Hopkins University, MD, USA
The Society to Improve Diagnosis in Medicine and Johns Hopkins University School of Medicine are pleased to announce the 5th international conference on DIAGNOSTIC ERROR IN MEDICINE (DEM)—2012. The pre-conference day on Sunday, November 11, 2012 will provide four half day Short Courses and a half day Research Summit in the afternoon. The full three day DEM conference will be held November 12–14, 2012. All will be held on the Johns Hopkins East Baltimore Medical Campus.
We hope to build on the past successful meetings by continuing the discussion of diagnostic errors and expanding the constituency of advocates, academicians, healthcare providers, payers, policy and risk managers and patients dedicated to addressing this key problem.
Purpose and Scope
7–9 November 2012 International Conference on Nanotechnology in Medicine (NanoMED)
NanoMED will cover the following topics:
- Nanotechnology in:
- Tissue Engineering & Biomaterial Science
- Nanoscale tissue scaffolds
- Nanoscale biomaterial surface modification
- Enzyme responsive tissue scaffolds
- Guiding stem cell differentiation
- Diagnosis and Imaging:
- Quantum Dot Imaging
- Image enhancing particles
- Drug Delivery (Nano-Pharmacology):
- Targeted drug delivery
- Nano-vehicle delivery systems
- Photo-dynamic therapy
26 September 2012 Biomarkers 2012 - “Successful Strategies & Developments in Biomarkers”
Key Themes Discussed at this Conference:
- Biomarker Discovery & Validation - Government policies & strategies
- Companion Diagnostics & Personalized Medicine
- Safety & Biomarkers in Clinical Development
- Enabling Technologies to Maximise Biomarker Identification
- Discuss how biomarkers can accelerate your clinical development
- Design strategies for success in early phase trials
- Showing clinical utility of biomarkers to improve diagnosis & make informed decision making
- See how improvements in technologies are leading to better efficiency of biomarkers
- Analyze biomarkers and their role in drug development
- Development and Application of Clinical Safety Biomarkers with a focus on imaging biomarkers
- Assess preclinical safety considerations
- Identifying current developments in Biomarkers & ways to overcome threats
- Discovering successful business models - Opportunities & Challenges
- Emerging stratified medicine via successful partnerships
- Network in our combined exhibition and catering area
- Evening networking reception for all attendees
27–30 August 2012 INDC2012—The International Nutrition and Diagnostics Conference 2012
Carolinum, Czech Republic
INDC2012—The International Nutrition and Diagnostics Conference 2012 is an international forum for scientific discussion focused on understanding the relationship and connections between nutrition and clinical diagnostics. The aim of this multidisciplinary conference is to bridge the gaps between the specialists and fields of science as diverse as nutrition, clinical biochemistry, food technology, analytical chemistry and medicine.
- Novel trends in food processing and diagnostics (nanotechnology, etc.)
- Food safety
- Food microbiology (including antibiotic resistance)
- Functional foods
- Food supplements
- Phytochemicals and natural antioxidants
- Nutrition and health
- Foodborne diseases
- Food chain and gut ecology
- Nutrition and development of immunity
- Nutrition and microbiota
- Nutrition related diseases
- Nutrition and clinical diagnostics
- Bringing together Biochemistry and Diagnostics
- Targeted Nutritional Therapy
- To drink or not to drink wine
- Beer and Health - Beer in a healthy diet, Why to drink Czech beer
- Polyphenols and health
- Chemistry in the human body
- Oxidative metabolism
- Phytoestrogens, isoflavones
- Probiotics and human health
- What to eat or not to eat to prevent cancer
- What to eat for weight control
- Analytical methods for analysis of biological materials
- Pediatric aspects of nutrition
6–10 August 2012 UltraPath XVI—Conference on Diagnostic Electron Microscopy, Basic Research and Oncology
The Society was formed in 1986 with the mission to support and promote the application of electron microscopy in pathological diagnosis and research of human diseases. Over the years the scope of biennial meetings expanded and includes immunohistochemistry, molecular and cellular biology. Now in the time of rapid increase of information and paradigm change in the field of health care we are facing new challenges. The conference addresses practicing surgical pathologists, trainees, and other scientists involved in pathological diagnosis and research.
Sessions during the Ultrapath XVI covered the following topics:
- Adult respiratory diseases
- Basic research – electron microscopy methods and applications
- Case reports and varia
- Ciliopathy derived diseases
- Ongoing electron microscopy value in diagnosis of neoplastic lesions
- Infectious agents
- Kidney – focus on structured deposits
- Mitochondria and diseases
- Pediatric respiratory diseases
- Transplantation pathology
- Ultrastructural neuropathology in the molecular era
29 July–1 August 2012 The 6th International Veterinary Vaccines and Diagnostics Conference
Cairns Queensland, Austrialia
The First IVVDC Conference was held in Madison WI in 1997 (Chair R.D. Schultz), the 2nd in Oxford England 2000 (Chair Lewis Thomas), the 3rd in Guelph Canada 2003 (Chair Pat Shewen) the 4th in Oslo Norway 2006 (Chair Arve Lund) and the 5th in Madison, USA (Chair Ronald David Schultz). These were all excellent conferences! The original and continuing purpose of the IVVDC is to bring together people from the Private Sector (Industry, Veterinary Practice) and the Public Sector (Government and Academia) to discuss issues pertaining to the development and use of all Veterinary Vaccines and Diagnostics for multiple animal species. The 6th IVVDC will be located in an ideal setting, in the beautiful city of Cairns in Australia’s tropical East Coast near the Great Barrier Reef. We hope to see many old faces and some new as we continue to make major inroads into Veterinary Immunology, Microbiology, Vaccinology and Diagnostics.
- Control of emerging and re-emerging infections
- Companion animal vaccines and diagnostics
- Production animals vaccines and diagnostics
- Aquaculture vaccines and diagnostics
- Wildlife vaccines and diagnostics
- Novel adjuvant and vaccine delivery systems
23–25 July 2012 4th Annual Ubiquitin Drug Discovery & Diagnostics Conference 2012
Philadelphia, PA, USA
The 4th Annual Ubiquitin Drug Discovery & Diagnostics Conference will be held from Monday, July 23rd through Wednesday, July 25th, 2012 at Four Seasons Hotel in Philadelphia, PA, USA.
This premier conference in the ubiquitin field will host an exciting cast of ubiquitin-focused professionals from the academic, pharmaceutical, biotech and business communities.
The three-day conference and workshop is unique in its focus on drug discovery within the ubiquitin pathway, and in its balance of both industry and academic interests. Delegates will have the opportunity to participate in a series of roundtable discussions and poster sessions, and to network with like-minded researchers from around the world.
An innovative pre-conference workshop covering various topics in assays and assay platforms, substrate identification, and ubiquitylation, will begin the program. The focus will be on technical advances in ubiquitin research and its application to the treatment of human disease.
12–15 February 2012 4th International Conference on Drug Discovery and Therapy
This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.
This conference organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
After the overwhelming success of the previous conferences held in Dubai in February 2008, 2010 and 2011 (where many Nobel Laureates attended), the fourth conference promises to be a much larger event with over 500 talks delivered and 36 thematic sessions with poster presentations and an associated commercial exhibition.
Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international pharmaceutical, academic and clinical communities.
17–19 November 2011 Association for Molecular Pathology (AMP) 2011 Annual Meeting
Grapevine, TX, USA
This three-day event will feature cutting-edge sessions and a keynote lecture presented by Carlo M. Croce, MD, The Ohio State University distinguished recipient of the 2011 AMP Award for Excellence in Molecular Diagnostics.
Programming includes poster sessions and invited speakers for workshop and plenary sessions in the major areas of clinical molecular diagnostics including
Multianalyte Testing in Infectious Diseases
Next Generation Sequencing
SNP Arrays in Hematopathology and Solid Tumors
Circulating Tumor Cells and Nucleic Acids
Copy Number Variation in Genetic Disease
Next Generation Laboratory Automation
Regulatory and Reimbursement Issues
24–26 October 2011 The Diagnostic Error in Medicine Medicine
Chicago, IL, USA
We are pleased to announce the 4th international conference on DIAGNOSTIC ERROR IN MEDICINE – 2011 to be held in association with the annual meeting of the Society for Medical Decision Making. We hope to build on the past successful meetings by continuing the discussion of diagnostic errors and expanding the constituency of advocates dedicated to addressing this key problem.
The ultimate goal of this conference is to improve patient safety by reducing the likelihood of diagnostic error in medicine. Minimizing diagnostic error is an essential component of safe patient care, and towards this end the conference activities are organized to summarize the current state of the field, review active research, and consider emerging educational and research themes that should be implemented to minimize diagnostic error.
12–14 October 2011 7th European Meeting on Molecular Diagnostics
Scheveningen The Hague, The Netherlands
This is the 7th in a series of meetings, devoted to all aspects of molecular diagnostics in disease and pathology of humans. The Scheveningen Meeting is organised every two years. These meetings are a continuation of the Benelux- and European meetings. However the scope of the meeting has expanded to include other amplification techniques, general probe technology and more laboratory disciplines.
The emphasis of the meetings will continue to be on novel technology and its consequences for (new) clinical molecular diagnostics. The format of the meetings will also be maintained: general, introductory lectures by internationally renowned experts in combination with free presentations in dedicated workshops. Poster session and industrial exhibits will be an integrated part of the meeting. In conjunction with the meeting a number of business meetings of the participating society and sponsors will be organised.
The sponsoring companies are enable to organise specific training and other activities before and after the meeting. The previous meetings had an informal and open atmosphere. The renowned Kurhaus hotel is the ideal venue to maintain these characteristics. It also means that the number of participants will be restricted. Timely registration will avoid disappointment. Wens Travel bv handles the practical part of the meeting. All parties involved invite you to become part of a tradition.
29–30 September 2011 Molecular Diagnostics World Congress
South San Francisco, CA, USA
Welcome to the 4th annual Molecular Diagnostics World Congress, this year's event takes place at the South San Francisco Conference Center. The conference will be co-located with the Lab-on-a-Chip World Congress, Microarray World Congress and Single Cell Analysis Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.
- Molecular Diagnostics & Biomarkers
- PGx and Personalized Medicine
- Emerging Technologies
- Clinical Applications of Molecular Diagnostics
- Commercial & Regulatory Perspectives
Edinburgh, Scotland, UK
A joint event between the Scottish Clinical Skills Network, the Scottish Intensive Care Society, and the Royal College of Physicians of Edinburgh, with support from Healthcare Improvement Scotland, aims to help us understand and reduce diagnostic error in the UK.
Diagnosis is a fundamental component of clinical medicine - good diagnosticians are revered by their peers and treasured by their patients. Yet diagnostic error is the second most common preventable error made by doctors, with major implications for patient safety and quality of care. Many factors result in diagnostic error. Some, such as lack of knowledge, are easily identifiable and correctable. Others are more difficult to recognise and rectify. In particular the thought processes, both conscious and unconscious, leading to the formulation of a diagnosis, are fraught with difficulty and prone to error. Cognitive errors are frequent and compounded by affective biases.This symposium will explore the ways doctors think, and provide a framework to understand how these processes may lead to diagnostic error and patient harm. World leading figures in the field will explain the concepts, and provide advice on how to improve individual diagnostic performance as well as strategies to improve patient safety in healthcare systems. The symposium will close with a panel discussion.
4–7 September 2010 10th INDC - International Nutrition & Diagnostics Conference
Prague, Czech Republic
The INDC 2010 continues former VITAMINS, NUTRITION AND DIAGNOSTICS Conferences. It aims to bridge the gaps between: nutrition and clinical diagnostics, fundamental science and industry, analytical chemistry and medicine.
The scientific programme of INDC 2010 will focus on nutrition in regard to health beneficiary and risks of chemical compounds in food. We are what we eat. We are healthy, ill or suffer from obesity because we eat too much healthy or unhealthy food? What to eat or not eat? To drink or not to drink? That´s a question for medical doctors, food producers and analytical chemists. The scientific programme includes oral presentations and poster sessions addressed to medicine, nutrition and bioanalytical chemistry.